| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Bacil Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹23.26 |
| 52 Week High | ₹23.26 |
| 52 Week Low | ₹4.68 |
| Beta | 0.60 |
| 1 Month Change | 44.20% |
| 3 Month Change | 200.91% |
| 1 Year Change | 334.77% |
| 3 Year Change | 198.21% |
| 5 Year Change | 911.30% |
| Change since IPO | 696.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524516 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 8.1% | -0.8% | -2.0% |
| 1Y | 334.8% | 55.7% | 41.1% |
Return vs Industry: 524516 exceeded the Indian Pharmaceuticals industry which returned 58.3% over the past year.
Return vs Market: 524516 exceeded the Indian Market which returned 42.5% over the past year.
Price Volatility
| 524516 volatility | |
|---|---|
| 524516 Average Weekly Movement | 1.9% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524516's share price has been volatile over the past 3 months.
Volatility Over Time: 524516's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 2 | Ganpat Salekar | www.bacilpharma.com |
Bacil Pharma Limited engages in the pharmaceuticals business. The company was incorporated in 1987 and is based in Mumbai, India.
Bacil Pharma Limited Fundamentals Summary
| 524516 fundamental statistics | |
|---|---|
| Market cap | ₹137.00m |
| Earnings (TTM) | -₹945.61k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-144.9x
P/E RatioIs 524516 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524516 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹945.62k |
| Earnings | -₹945.61k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 2.5% |
How did 524516 perform over the long term?
See historical performance and comparison